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Abstract: BACKGROUND The use of reverse total shoulder arthroplasty (RTSA) has spread worldwide
as a result of an expansion of indications and an aging society. However, the value of RTSA for very old
patients is rarely analyzed. This study was conducted to investigate the outcome of primary RTSA in
patients older than 80 years. METHODS We identified 171 shoulders (159 patients) treated with RTSA at
an age of more than 80 years between January 2005 and March 2018. The primary outcome parameters
were Subjective Shoulder Value (SSV) and the Constant-Murley score, mortality, complications, and
reoperation rates. Secondary outcomes were adverse radiographic outcomes. A minimum follow-up of 1
year was accepted in 14 patients (8%) because of these patients’ older age. RESULTS We included 171
cases (159 patients; 120 female) with a mean age of 84 ± 3 years (range 80.1-94). The main indication
for RTSA was cuff tear arthropathy (43%), isolated rotator cuff tear (22%), and fracture (21%). A total
of 136 patients (79%) were eligible for physical examination with a mean follow-up of 41 ± 25 months
(12-121). Relative Constant-Murley scores improved significantly from 39% ± 19% to 77% ± 16% and
SSV from 31% ± 18% to 74% ± 22%. The range of motion and force improved significantly as well. The
surgical site complication rate was 30%, with a reoperation rate of 8% (13 patients) mainly due to fracture
and glenoid loosening. The overall mortality was 16% with a mean time to death of 53 ± 31 months (95%
confidence interval 15, 120), thereby no higher than the age-adjusted, expected mortality rate without
this procedure. CONCLUSION Despite a quite high postoperative complication rate, RTSA is a valid
therapeutic option in patients older than 80 years, with an unexpectedly low medical complication rate
and good to excellent improvement of shoulder function and pain.
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Background: The use of reverse total shoulder arthroplasty (RTSA) has spread worldwide as a result of an expansion of indications and
an aging society. However, the value of RTSA for very old patients is rarely analyzed. This study was conducted to investigate the
outcome of primary RTSA in patients older than 80 years.
Methods: We identified 171 shoulders (159 patients) treated with RTSA at an age of more than 80 years between January 2005 and
March 2018. The primary outcome parameters were Subjective Shoulder Value (SSV) and the Constant-Murley score, mortality, com-
plications, and reoperation rates. Secondary outcomes were adverse radiographic outcomes. A minimum follow-up of 1 year was
accepted in 14 patients (8%) because of these patients’ older age.
Results: We included 171 cases (159 patients; 120 female) with a mean age of 84  3 years (range 80.1-94). The main indication for
RTSAwas cuff tear arthropathy (43%), isolated rotator cuff tear (22%), and fracture (21%). A total of 136 patients (79%) were eligible
for physical examination with a mean follow-up of 41  25 months (12-121). Relative Constant-Murley scores improved significantly
from 39%  19% to 77%  16% and SSV from 31%  18% to 74%  22%. The range of motion and force improved significantly as
well. The surgical site complication rate was 30%, with a reoperation rate of 8% (13 patients) mainly due to fracture and glenoid loos-
ening. The overall mortality was 16% with a mean time to death of 53  31 months (95% confidence interval 15, 120), thereby no
higher than the age-adjusted, expected mortality rate without this procedure.
Conclusion: Despite a quite high postoperative complication rate, RTSA is a valid therapeutic option in patients older than 80 years,
with an unexpectedly low medical complication rate and good to excellent improvement of shoulder function and pain.
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Reverse total shoulder arthroplasty (RTSA) implantation
rates continue to grow worldwide due to an extension of the
indications as well as an aging society.7,16,20,24,27 The
original Grammont prosthesis was used for rotator cuff
arthropathy associated with pseudoparalysis of elevation.12
Since then, reliable clinical results have expanded the range
of indications. Nowadays, RTSA is used for rheumatoid
arthritis, osteoarthritis especially with B and C
glenoids,2,30 massive rotator cuff tears, primary treatment
of proximal humeral fractures, as well as an elegant salvage
option for failed open reduction and internal fixation
(ORIF) of shoulder fractures or shoulder prostheses.10
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Another aspect of the rising number of implantations
might be an aging society with a mean life expectancy
higher than 80 years in Western countries.15,18 Anatomic
shoulder arthroplasty has yielded promising results in
elderly patients,9 with a complication rate comparable to
that in younger patients.8,23
The outcome of RTSA in patients older than 80 years is
underreported, with only a few studies in the current liter-
ature.5,19,29 Recently, Clark et al5 published a series of 179
patients, 81 of them personally followed up after primary
RTSA mainly for cuff tear arthropathy (80%) and osteo-
arthritis (8%), and found satisfactory improvement in
clinical outcomes and an acceptable surgical complication
rate of 12%. The main complications were acromial frac-
ture in 4%, delayed wound healing in 3%, and heterotopic
ossification in 1.7%. Mangano et al19 and Triplet et al29,
studying 2 cohorts smaller than 33 patients with a follow-
up between 24 and 87 months, reported promising
improvement in clinical outcomes and a surgical nonsys-
temic complication rate of 10% and 15%, respectively.
These complication rates resulted in very low reoperation
rates between 0 and 2%.17-19 Clark et al5 described an
overall mortality of 19% in the median time to death of
67.7 months in the study population. The data are prom-
ising and lend support to RTSA for elderly patients.
Nevertheless, the overall reported patient numbers are
small, and further research is justified.
Therefore, this study aimed to evaluate the complication
rate and subjective and objective outcomes of RTSA in
patients older than 80 years in a comprehensive patient
cohort. We hypothesized that RTSA is a treatment that (1)
reliably improves function and pain and (2) has a low
overall risk for surgical site complications or major medical
complications (measured as death, pulmonary embolism,
deep vein thrombosis, acute coronary syndrome, renal
failure, stroke) and a low revision rate.
Materials and methods
Patient selection
Our institutional RTSA database documents 1172 consecutive
RTSA procedures between January 2005 and March 2018. Of
these, 186 surgeries were performed in patients older than 80
years. To be included in the study, patients had to be older than 80
years, the operation had to be a primary RTSA, and a complete
clinical and radiographic follow-up as well as informed consent to
participate in the study had to be available. All revision arthro-
plasties were excluded. Of the 186 cases, 15 were revision
arthroplasties, leaving 171 cases for this study (Fig. 1).
Clinical and radiologic examination
All patients underwent a standardized clinical and conventional
radiographic examination by an examiner different from the
operating surgeon sequentially at each regular consultation. The
clinical examination included assessment of the Subjective
Shoulder Value (SSV)11 and functional21 scoring according to
Constant-Murley6,11 including measurement of abduction strength
with a validated dynamometer.
Mortality, complications, and revision surgery
The overall mortality was evaluated. As major medical compli-
cations, we included stroke, acute coronary syndrome, pulmonary
embolism, pneumonia, renal failure, and deep vein thrombosis.
All revision surgeries were recorded.
Surgical technique
The surgeries were performed by 11 different, fellowship-trained
staff shoulder surgeons in a specialized academic unit. The op-
erations were done in a standardized manner. Antibiotic prophy-
laxis with cefuroxim 1.5 g (Fresenius Kabi, Kriens, Switzerland)
was administered intravenously 30 minutes before skin incision.
The patient was placed in a beach chair position. For patient-
controlled pain control, an interscalene catheter with ropivacaine
(Sintetica, Switzerland) was installed preoperatively and with-
drawn 2 days postoperatively in most patients.3,4 The surgery was
done using additional general anesthesia in 116 cases and under
regional anesthesia and sedation alone in 55 cases. Disinfection
with Betaseptic (Mundipharma Medical Company, Basel,
Switzerland) and draping was done with 3 rectangular drapes, 2 U-
shaped drapes, and an adhesive incisional drape (Ioban, 3M, Saint
Paul, MN, USA) in all the patients. A deltopectoral approach was
used in 166 cases, leaving the cephalic vein laterally. The other 5
patients were operated with a superolateral, deltoid-splitting
approach. The humeral head was resected, and the stem was
inserted in 0-20 of retroversion. Additional cementation was
decided on intraoperatively, depending on bone quality and press-
fit stem fixation. The glenoid was reamed to create a flat surface.
Subchondral bone was only removed if it prevented stable posi-
tioning of the prosthetic component with the baseplate flush with
the inferior glenoid rim. The baseplate was implanted with a
neutral version and neutral to slight inferior inclination not
exceeding 10. All patients received a Zimmer Anatomical/
Reverse RTSA with a standard or fracture shaft. If possible, a
transosseous subscapularis refixation using No. 2 FiberWire
(Arthrex, Naples, FL, USA) was carried out. Aftercare consisted
of wearing a sling for 6 weeks allowing passive mobilization and
minimal active use of the arm. Active range of motion exercises
were carried out without weight through weeks 7-12.
Data collection, statistical analyses, and literature
review
The patient’s data were collected in REDCap Electronic Data
Capture system version 8.6.1 (Vanderbilt University, Nashville,
TN, USA) anonymously.14
All statistical analyses were performed with SPSS software,
version 24.0 (IBM, Armonk, NY, USA). The normal distribution
of variables was tested with the Shapiro-Wilk test and compared
pre- and postoperative scores with the paired t test (parametric
data) or the Wilcoxon rank-sum test (nonparametric distribution).
Fisher exact test was used for categorical variables. A P value of
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less than .05 was considered significant. Because of the given




One hundred fifty-nine patients with a total of 171 shoul-
ders were included. The mean age at surgery was 84  3
years (80.1-94) for the 39 men (25%) and 120 women
(75%); the dominant side was affected in 61% of the cases.
The mean body mass index was 25.9  4. The most
common ASA classification was grade II in 83 cases (49%)
and grade III in 82 cases (48%), followed by 5 cases (3%)
grade I and 1 (1%) case grade IV. The underlying pathology
was cuff tear arthropathy in 74 cases (43%), massive rotator
cuff tear in 38 cases (22%), osteoarthritis in 21 cases
(12%), primary fracture treatment in 23 cases (13%), con-
version from fracture treatment with ORIF in 13 cases (8%)
and 2 cases (1%) of shoulder instability. The humeral stem
was cemented in 54% of the cases (92 shoulders). Of the
identified 171 shoulders (159 patients), 31 (18%) (30 pa-
tients) were not available for further clinical examination.
Ten patients (6%) passed away before regular follow-up;
none of these deaths could be related to the implantation of
the prosthesis. Eighteen patients (11%) were unable to
travel for further examination because of high age or poor
health, 3 patients (1%) could not be contacted. This left a
total of 140 cases. Four of these were excluded for further
analysis because of glenoid component dislocation with
massive bone loss. They were revised to hemiarthroplasty
in 3 cases and persistent implantation of a spacer in 1 case.
A total of 136 cases (79%) were followed up clinically
and radiologically. Fourteen (10%) had a minimum follow-
up of 1 year and 122 (90%) of at least 2 years. The mean
>80 years old, 
n = 186
Physical Examination n = 136 (79%)
- mind. 1 year FUP n = 14 (10%)





Lost to Follow-up  (n=31) (100%) (18%)
• Passed away before follow-up (n=10) (32%) (6%)
• Unable to travel due to Age / comorbidities (n= 18) (58%) (11%)
• Unknown (n= 3) (10%) (1%)
Available for examination 
n =140 (82%)
Excluded
• Conversion to Hemiarthroplasty/Spacer n = 4
Eligible from 01/2015 – 03/2018
n = 1172
Figure 1 Flowchart demonstrating patient selection. FUP, follow-up period; ORIF, open reduction and internal fixation.
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follow-up was 41  25 (minimum 12, maximum 121)
months.
Mortality
Of the 159 patients older than 80 years who received an
RTSA, a total of 26 patients (16%) in 30 cases (18%) died
during the follow-up period. They passed away at a mean
time of 53  31 months (95% confidence interval 15, 120),
all unrelated to the implant surgery. The earliest post-
surgical death occurred at 15 months postoperatively.
Complications and revisions
During the hospitalization, no major medical complications
occurred. There were 3 patients with treatment-requiring
dyspnea. In 2 cases, the dyspnea was explained by the
regional anesthesia that involved the diaphragm. Pulmonary
embolism was ruled out in these 2 cases but confirmed in
the third. There were 2 cases of acute decompensation of
chronic heart failure, which could be treated conservatively.
No patient died within the first 15 months postoperatively.
No other major complications were reported to us in the
postoperative period.
A total of 30 (18%) local complications occurred,
requiring reoperation in 13 cases (8%). These were peri-
prosthetic fractures of the humeral stem in 6 cases (4%),
fractures of the acromion in 5 cases (3%), and the scapular
spine in 3 cases (2%). All fractures occurred post-
operatively, and 38% were related to a fall. Five of the 6
stem fractures were treated operatively; all acromion and
scapular spine fractures were treated conservatively. There
were 9 cases (5%) of glenoid loosening potentially related
to a fall. Four of them with complete displacement (2
following a definite fall) underwent revision surgery.
Overall, there were 4 periprosthetic infections (2%), of
which 2 needed multiple revisions surgeries. The other 2
were treated with antibiotics without revision surgery. In 2
cases, a transient neurologic lesion of the radial or axillar
nerve was recorded. There were 2 postoperative hema-
tomas; 1 was treated surgically. Another patient underwent
debridement for painful scarring.
Clinical and radiographic follow-up
A total of 136 cases were followed up for this study: the
Constant-Murley scores as well as SSVs (P < .01) signif-
icantly improved over the preoperative state. The mean
pain score was reduced from 6  4 points preoperatively to
14  2 Constant-Murley score points, where 15 points are
defined as no pain and 0 points as the worst imaginable
pain21 (P < .01). The mean active anterior elevation
improved from 64  41 to 109  29, the mean active
abduction from 62  37 to 113  34, and the mean
internal rotation from 4  2 to 5  3 (Constant-Murley
score rating). External rotation did not change significantly.
The mean strength improved significantly from 0  1 kg
preoperatively to a low 2  2 kg. Overall, 76% of the pa-
tients rated their outcome as good or very good. The
Constant-Murley scores and SSVs categorized by indica-
tion are shown in Table I.
A subgroup analysis between primary fracture treatment
and revision following ORIF showed significantly superior
results for primary fracture treatment. The comparison of
primary fracture arthroplasty vs. ORIF revisions were 62 
15 vs. 48  15 (P ¼ .026), 78% þ 17% vs. 64%  18% (P
¼ .035), and 79%  18% vs. 58%  21% (P ¼ .009) for the
Absolute Constant Score, Relative Constant Score, and
SSV.
In the follow-up period, 69 cases (40%) of notching and
31 cases (18%) of heterotopic ossifications were recorded.
A subgroup analysis for notching and heterotopic ossifi-
cations revealed no statistically significant difference in the
Constant-Murley score or SSV.
Discussion
The use of reverse total shoulder replacement is increasing
worldwide because of an expansion of indications and the
aging of society.16,24,32 In the United States, RTSA sur-
passed the use of aTSA already in the year 2014din-
creasing by 75% from 2011 through 2014.21 In addition, the
continuously aging society will challenge the health care
systems substantially. The elderly candidate for a total joint
replacement may have more medical and surgical compli-
cations, a longer hospital stay, higher mortality, and prob-
ably higher morbidity because of complicating conditions
such as diabetes or peripheral vascular disease and the high
risk of low-energy injury during recovery.13,22,28,31 There-
fore, the benefit of joint replacement surgery has to be
documented, and relevant predictors for poor clinical out-
comes have to be identified. The literature concerning
RTSA in patients older than 80 years contains only a few
studies with mostly small cohorts.1
This study presents an analysis of the results in 136
shoulders of 127 octogenarians receiving a primary RTSA.
The overall outcome was good or excellent in 76% of the
patients, with a significant improvement in the Constant-
Murley score and SSV. According to Simovitch et al,26 the
minimal clinically important difference for the Constant-
Murley score was reached by 95% of the patients. The
procedure did not increase the mortality over age-adjusted,
expected mortality of an overall population.25 Morbidity
was unexpectedly low in these patients uniformly treated
with the assistance of regional anesthesia. Pain was well
controlled, and activities of daily living requiring the
assistance of the arm were significantly improved.
Overall, the SSV and the results of the functional scores
essentially and often at least doubled in each of the in-
dications studied except for instability: instability patients
had the highest preoperative scores, obtained a smaller gain
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but essentially an outcome of three-quarters of a normal
shoulder. In contrast, the final absolute outcome, how-
ever, was inferior in revisions of ORIF than in any other
indication studied. Although this was not the scope of
this study, as the results of primary RTSA for acute
fractures were much better than those of revisions of
ORIF, an attempt at ORIF may need to be only very
carefully be considered in this age group. On the other
hand, if ORIF has failed, a revision to RTSA is well
worthwhile as the gain in each score is approximately
the same as in any other indication.
These findings are corroborated by reports on smaller
cohorts that in addition have a much lower follow-up
rate. Based on 179 octogenarians of whom unfortu-
nately only 81 (45%) could be followed up for a mean
of 27.4 months, Clark et al5 reported good improvement
on strength and range of motion. Triplet et al29 showed
good clinical results in 18 patients with TSA and 33
patients with RTSA at an age older than 80 years.
Mangano et al’s19 data on 27 of 52 elderly patients (re-
examination rate of 51%), showed a satisfying quality of
life as measured by the 12-Item Short Form Health
Survey and scored well on the American Shoulder and
Elbow Surgeons Standardized Shoulder Assessment
Form.5,19,29
This study documents that RTSA performed under
regional or combined regional anesthesia in such pa-
tients is associated with no increase in mortality and has
a low morbidity. This may be due to good patient se-
lection among others reflected by 97% of the patients
having ASA II and III scores. The role of regional
anesthesia or experienced treatment teams cannot be
quantified in this study, because there was no alternative
treatment protocol. Despite the low general health risk
of the procedure and the good clinical outcome testified
by a high satisfaction rate of the patients, the post-
operative local complication rate was 18% and the
reoperation rate was 8%. This is high but compatible
with the literature.1 Clark et al5 had in their study 12%
surgical and 3% major medical complications and need
of reoperation in 1.7% (2 dislocations, 1 glenoid
loosening). Triplet et al29 described a rate of 15% sur-
gical complications but no reoperation. Mangano
et al19 reported 3 surgical complications but only 1
reoperation following an iatrogenic shaft fracture.18 Koh
investigated the 30-day complication rate of RTSA vs.
anatomic shoulder arthroplasty (82.9%) or hemi-
arthroplasty (17.1%) in 11,450 patients and found sig-
nificant differences in complication rates with 15.3% for
‘‘very old’’ (>80 years, 1708 shoulders), 8.2% for
’’elderly’’ (65-79 years, 6073 shoulders), and 6.8% for
‘‘young’’ (<65 years, 3669 shoulders) patients.17 A
major factor in the development of short- and long-term
complications can be the increased tendency of elderly
patients to fall in combination with poor bone quality.
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definitively related to a fall. Furthermore, 38% of the
fractures of the humeral stem, the acromion, and the
scapula spine were related to a fall.
Our study has limitations. First is the lack of personal
follow-up in 18% of the cases. Given the patients’ age, the
authors believe that this rate is acceptable. Thirty-two
percent (10 shoulders) in the lost-to-follow-up group passed
away and 58% (18 shoulders) were unable to travel to our
institution for follow-up because of very high age and
comorbidities. For all except 1 of those 31 cases, telephone
calls could exclude major complications. Another obvious
limitation is the minimum follow-up of 1 year in 8% of the
examined cases. This was knowingly accepted given the
patients’ high age and the generally limited data available on
this topic. Furthermore, this study was a retrospective case
series; nevertheless, the follow-up and data assessment of the
patients occurred on a regular and prospective basis with a
standardized follow-up after 2-4 years postoperatively.
Despite these limitations, this represents the largest
cohort of octogenarians with an RTSA and systematic
follow-up. Our study shows that improvement of pain and
functional status of the upper limb can be dramatically
improved with RTSA without inappropriate risk to the
general health of these patients.
Conclusion
RTSA performed with the assistance of regional anes-
thesia is a valid therapeutic option, with an unexpectedly
low medical complication rate and a good to excellent
subjective and objective clinical outcome in patients
older than 80 years.
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